CAS 21561-09-1: 4-Quinazolinamine, 6,7-dimethoxy-N-phenyl-

Description: 4-Quinazolinamine, 6,7-dimethoxy-N-phenyl- is an organic compound characterized by its quinazoline core, which is a bicyclic structure containing both benzene and pyrimidine rings. This compound features two methoxy groups at the 6 and 7 positions of the quinazoline ring, enhancing its solubility and potentially influencing its biological activity. The presence of a phenyl group at the nitrogen position contributes to its lipophilicity, which may affect its interaction with biological targets. Typically, compounds of this class are studied for their pharmacological properties, including potential anti-cancer and anti-inflammatory activities. The molecular structure allows for various interactions with enzymes and receptors, making it a subject of interest in medicinal chemistry. Additionally, the compound's stability, reactivity, and solubility in various solvents can be influenced by the functional groups present. Overall, 4-Quinazolinamine, 6,7-dimethoxy-N-phenyl- represents a significant structure in the field of drug discovery and development.

Formula: C₁₆H₁₅N₃O₂

4-Quinazolinamine, 6,7-dimethoxy-N-phenyl-

CAS: 21561-09-1

• Formula: C₁₆H₁₅N₃O₂
• Purity: 98%
• Color and Shape: Solid
• Molecular weight: 281.3092

6,7-Dimethoxy-N-Phenylquinazolin-4-Amine

CAS: 21561-09-1

• Purity: 97%
• Molecular weight: 281.31g/mol

WHI-P258

CAS: 21561-09-1

• Purity: ≥98%
• Molecular weight: 281.31g/mol

WHI-P258

CAS: 21561-09-1

WHI-P258, a weak JAK3 inhibitor, is used as a negative control in drug development.

• Formula: C₁₆H₁₅N₃O₂
• Purity: 99.64% - 99.95%
• Color and Shape: Solid
• Molecular weight: 281.31

4-Phenylamino-6,7-dimethoxyquinazoline

CAS: 21561-09-1

4-Phenylamino-6,7-dimethoxyquinazoline is a synthetic compound that has been shown to have anticancer activity. It is …

• Formula: C₁₆H₁₅N₃O₂
• Purity: Min. 95%
• Molecular weight: 281.31 g/mol